Cargando…

Alemtuzumab for the treatment of multiple sclerosis

Detalles Bibliográficos
Autores principales: Willis, Mark D, Robertson, Neil P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386803/
https://www.ncbi.nlm.nih.gov/pubmed/25848299
http://dx.doi.org/10.2147/TCRM.S80112
_version_ 1782365212629794816
author Willis, Mark D
Robertson, Neil P
author_facet Willis, Mark D
Robertson, Neil P
author_sort Willis, Mark D
collection PubMed
description
format Online
Article
Text
id pubmed-4386803
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43868032015-04-06 Alemtuzumab for the treatment of multiple sclerosis Willis, Mark D Robertson, Neil P Ther Clin Risk Manag Review Dove Medical Press 2015-03-31 /pmc/articles/PMC4386803/ /pubmed/25848299 http://dx.doi.org/10.2147/TCRM.S80112 Text en © 2015 Willis et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Willis, Mark D
Robertson, Neil P
Alemtuzumab for the treatment of multiple sclerosis
title Alemtuzumab for the treatment of multiple sclerosis
title_full Alemtuzumab for the treatment of multiple sclerosis
title_fullStr Alemtuzumab for the treatment of multiple sclerosis
title_full_unstemmed Alemtuzumab for the treatment of multiple sclerosis
title_short Alemtuzumab for the treatment of multiple sclerosis
title_sort alemtuzumab for the treatment of multiple sclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386803/
https://www.ncbi.nlm.nih.gov/pubmed/25848299
http://dx.doi.org/10.2147/TCRM.S80112
work_keys_str_mv AT willismarkd alemtuzumabforthetreatmentofmultiplesclerosis
AT robertsonneilp alemtuzumabforthetreatmentofmultiplesclerosis